Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$28.73 USD
+0.11 (0.38%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $28.75 +0.02 (0.07%) 5:46 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Earnings News For SUPN
-
Supernus: Q4 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates
-
Supernus: Q3 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Supernus Pharmaceuticals (SUPN) Reports Q2 Loss, Misses Revenue Estimates
-
Supernus: Q2 Earnings Snapshot
-
Supernus: Q1 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates
-
Supernus: Q4 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Q4 Earnings and Revenues Lag Estimates
-
Supernus Pharmaceuticals (SUPN) Earnings Expected to Grow: Should You Buy?
-
Supernus Pharmaceuticals (SUPN) Misses Q3 Earnings Estimates
-
Supernus: Q3 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Beat Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Miss Estimates
-
Supernus Pharmaceuticals (SUPN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Surpass Estimates
-
Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue Estimates